Dr Ramya Bhatia (PhD, MRes, BSc) | The University of Edinburgh

Senior Research Fellow

HPV Research Group
Edinburgh Pathology

Tel: 0131 242 6625
Email: ramya.bhatia@ed.ac.uk

Edinburgh Pathology

Street: Human Papillomavirus (HPV) Research Group
The University of Edinburgh
MRC Centre for Reproductive Health
Queen's Medical Research Institute
47 Little France Crescent
City: Edinburgh
Post code: Eh16 4TJ

Publications

HPV infection and pre-term birth: a data-linkage study using Scottish Health Data 8 Mar 2019 In: Wellcome Open Research , vol. 4, pp. 48
DOI: https://doi.org/10.12688/wellcomeopenres.15140.1
Research output: Contribution to Journal › Article (Published)
The potential of biobanked liquid based cytology samples for cervical cancer screening using Raman spectroscopy 17 Jan 2019 In: Journal of biophotonics
DOI: https://doi.org/10.1002/jbio.201800377
Research output: Contribution to Journal › Article (E-pub ahead of print)
Nine years of the SCOTTISH HPV ARCHIVE - A resource support for basic and applied HPV research Dec 2018
DOI: https://doi.org/https://www.eurogin.com/2018/images/pdf/Abstracts-Part1.pdf
Research output: Contribution to Conference › Abstract (Published)
Clinical validation of the Liferiver Harmonia HPV assay using the VALGENT-4 framework Dec 2018
DOI: https://doi.org/https://www.eurogin.com/2018/images/pdf/Abstratcs-Part2.pdf
Research output: Contribution to Conference › Abstract (Published)
Validation of EUROArray HPV test using the VALGENT framework Nov 2018 In: Journal of Clinical Virology, vol. 108, pp. 38-42
DOI: https://doi.org/10.1016/j.jcv.2018.09.005
Research output: Contribution to Journal › Article (Published)
Development of an in-house ELISA to detect anti-HPV16-L1 antibodies in serum and dried blood spots (6 pages) 22 Oct 2018 In: Journal of Virological Methods, vol. 264, pp. 55-60
DOI: https://doi.org/10.1016/j.jviromet.2018.10.007
Research output: Contribution to Journal › Article (E-pub ahead of print)
Host chemokine signature as a biomarker for the detection of pre-cancerous cervical lesions 6 Apr 2018 In: Oncotarget, vol. 9, pp. 18548-18558
DOI: https://doi.org/10.18632/oncotarget.24946
Research output: Contribution to Journal › Article (Published)
Clinical validation of the full genotyping clart4s HPV assay on Surepath collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening 2018
DOI: https://doi.org/https://www.eurogin.com/2018/images/pdf/Abstratcs-Part2.pdf
Research output: Contribution to Conference › Abstract (Published)
An evaluation of a novel single tube method for extended genotyping of Human Papillomavirus 13 Dec 2017 In: Journal of Clinical Microbiology
DOI: https://doi.org/10.1128/JCM.01687-17
Research output: Contribution to Journal › Article (E-pub ahead of print)
Changes in HPV prevalence following a national bivalent HPV vaccination programme in Scotland: a 7-year cross-sectional study Dec 2017 In: The Lancet Infectious Diseases, vol. 17
DOI: https://doi.org/10.1016/S1473-3099(17)30468-1
Research output: Contribution to Journal › Article (Published)
RNASeq analysis of differentiated keratinocytes reveals a massive response to late events during human papillomavirus type 16 infection, including loss of epithelial barrier function. Dec 2017 In: Journal of Virology
DOI: https://doi.org/10.1128/JVI.01001-17
Research output: Contribution to Journal › Article (Published)
Human Papillomaviruses (HPVs) 13 Sep 2017
DOI: https://doi.org/10.1007/978-3-319-51257-0_2
Research output: › Chapter (Published)
The massive decline of clinically relevant Human Papillomavirus (HPV) 16 and 18 infection in Scotland. 5 Apr 2017
Research output: Contribution to Conference › Paper (Published)
Oncogenicity of Human Papillomavirus (HPV) correlates with the GC content of viral genes 5 Apr 2017
Research output: Contribution to Conference › Poster (Published)
The role of SPZ1 in high risk Human Papillomavirus (HR-HPV) - caused oncogenesis. 5 Apr 2017
Research output: Contribution to Conference › Paper (Published)
Performance of HPV tests in screening of young vaccinated women- insights from the SHEVa study. 4 Mar 2017
Research output: Contribution to Conference › Poster (Published)
Performance of HPV tests in screening of young vaccinated women- insights from the SHEVA study. 3 Mar 2017
Research output: Contribution to Conference › Paper (Published)
The role of a potential-functional single nucleotide polymorphism (SNP) CXCR1 G827C in High risk–Human Papillomavirus (HR-HPV) related diseases. 2 Mar 2017
Research output: Contribution to Conference › Poster (Published)
A novel biomarker panel for triage of HPV positive women with high specificity for detection of clinically relevant cervical disease. 2 Mar 2017
Research output: Contribution to Conference › Poster (Published)
Human Papilloma Virus (HPV) Oral Prevalence in Scotland (HOPSCOTCH): A Feasibility Study in Dental Settings 18 Nov 2016 In: PLoS ONE, vol. 11, pp. e0165847
DOI: https://doi.org/10.1371/journal.pone.0165847
Research output: Contribution to Journal › Article (Published)

View all 26 publications on Research Explorer

This article was published on 12 May, 2024